Adam Houghton
Directeur/Bestuurslid bij Kojin Therapeutics, Inc.
Profiel
Currently, Adam Houghton is Vice President for AbbVie Ventures.
Lord Houghton is also on the board of Kojin Therapeutics, Inc.
He previously was Senior Research Scientist at Procter & Gamble Co. and Senior Director & Head-Search & Evaluation at Biogen Corp.
Ltd.
Adam Houghton received an MBA from Xavier University and an undergraduate degree from Yale University.
Actieve functies van Adam Houghton
Bedrijven | Functie | Begin |
---|---|---|
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Adam Houghton
Bedrijven | Functie | Einde |
---|---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01-09-2021 |
Biogen Corp. Ltd. | Directeur-Back Office Operatie | 28-02-2018 |
ELI LILLY AND COMPANY | Directeur/Bestuurslid | 28-02-2015 |
PROCTER & GAMBLE COMPANY | Hoofd Techniek/Wetenschap/O&O | 30-06-2005 |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - |
Opleiding van Adam Houghton
Xavier University | Masters Business Admin |
Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Bedrijven in privébezit | 4 |
---|---|
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
Biogen Corp. Ltd. | |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |